Search Results

Filter
  • 1-10 of  15,798 results for ""XENOGRAFTS""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts.

  • Authors : Bian B; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Parc Scientifique et Technologique de Luminy, Aix-Marseille Université and Institut Paoli-Calmettes, Marseille, France.; Bigonnet M

Subjects: Gene Expression Profiling* ; Heterografts*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*metabolism

  • Source: EMBO molecular medicine [EMBO Mol Med] 2017 Apr; Vol. 9 (4), pp. 482-497.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684

Record details

×
Academic Journal

Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation NSENL Reverses Cisplatin Resistance in Lung Cancer Xenografts.

  • Authors : Jin L; Department of Oncology, The First Affiliated Hospital, Jinan University, Guangzhou 510630, China.; † Department of Traditional Chinese Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510630, China.

Subjects: Heterografts* ; Neoplasm Transplantation* ; Panax*

  • Source: The American journal of Chinese medicine [Am J Chin Med] 2017; Vol. 45 (2), pp. 385-401. Date of Electronic Publication: 2017 Feb 23.Publisher: World Scientific Pub Country of Publication: Singapore NLM ID: 7901431 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts.

  • Authors : Monterrubio C; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Spain.; Paco S

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*metabolism ; Heterografts/Heterografts/Heterografts/*metabolism ; Neuroblastoma/Neuroblastoma/Neuroblastoma/*metabolism

  • Source: Pharmaceutical research [Pharm Res] 2015 Sep; Vol. 32 (9), pp. 2889-900. Date of Electronic Publication: 2015 Mar 14.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination.

  • Authors : Tedeschi PM; Departments of Pharmacology and Medicine, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA.; Kathari YK

Subjects: Aminopterin/Aminopterin/Aminopterin/*analogs & derivatives ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Heterografts/Heterografts/Heterografts/*drug effects

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2015 Jun; Vol. 75 (6), pp. 1247-52. Date of Electronic Publication: 2015 Apr 28.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology.

  • Authors : Rosfjord E; Bioconjugate Discovery and Development, Oncology Research Units, 401 North Middletown Road, Pearl River, NY 10965, United States; Pfizer Worldwide Research and Development, United States.

Subjects: Heterografts* ; Neoplasms, Experimental*/Neoplasms, Experimental*/Neoplasms, Experimental*/drug therapy; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2014 Sep 15; Vol. 91 (2), pp. 135-43. Date of Electronic Publication: 2014 Jun 17.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenografts.

  • Authors : Gao SQ; Department of Pharmaceutics and Pharmaceutical Chemistry/CCCD, University of Utah, Salt Lake City, Utah 84112, USA.; Sun Y

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Methacrylates*/Methacrylates*/Methacrylates*/chemistry

  • Source: Macromolecular bioscience [Macromol Biosci] 2009 Nov 10; Vol. 9 (11), pp. 1135-42.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101135941 Publication Model: Print Cited Medium: Internet ISSN: 1616-5195

Record details

×
Academic Journal

Possible mechanisms of improved radiation response by cytotoxic RNase, Onconase, on A549 human lung cancer xenografts of nude mice.

  • Authors : Kim DH; Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA.; Kim EJ

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Advances in experimental medicine and biology [Adv Exp Med Biol] 2007; Vol. 599, pp. 53-9.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 0121103 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.

  • Authors : Huxham LA; Medical Biophysics Department, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.; Kyle AH

Subjects: Transplantation, Heterologous*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; HCT116 Cells/HCT116 Cells/HCT116 Cells/*transplantation

  • Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2006 Feb; Vol. 78 (2), pp. 138-45. Date of Electronic Publication: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Print

Record details

×
Academic Journal

Tumour growth inhibition of human pancreatic cancer xenografts in SCID mice by cimetidine.

  • Authors : Sürücü O; Institute of Theoretical Surgery, Philipps University, Baldingerstr., 35033 Marburg, Germany.; Middeke M

Subjects: Transplantation, Heterologous*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Cimetidine/Cimetidine/Cimetidine/*pharmacology

  • Source: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2004 Mar; Vol. 53 Suppl 1, pp. S39-40. Date of Electronic Publication: Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9508160 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

Human osteosarcoma xenografts and their sensitivity to chemotherapy.

  • Authors : Bruheim S; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, 0310, Norway. ; Bruland OS

Subjects: Drug Resistance, Neoplasm* ; Drug Screening Assays, Antitumor* ; Transplantation, Heterologous*

  • Source: Pathology oncology research : POR [Pathol Oncol Res] 2004; Vol. 10 (3), pp. 133-41. Date of Electronic Publication: 2004 Sep 25.Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  15,798 results for ""XENOGRAFTS""